These data suggest that physicians may be preferentially selecting patients with type 1 diabetes thought to benefit most from either cardio-renal benefits of SGLT2i therapy or the weight reduction associated with GLP-1 RA, established in type 2 diabetes [17]
Genome-to-genome association analysis To systematically test for associations between human and Mtb genomic variants at the genome-wide level, we performed logistic mixed regression modeling implemented in SAIGE 65 version 1.1.6
While beneficial microbes and postbiotics enhance GLP-1 activity to support metabolic homeostasis, pathogenic species and harmful metabolites may inhibit this pathway, contributing to disease progression
On the other hand, the risks of HHF (HR 0.93, 95% CI 0.831.04 with GLP-1RAs and HR 0.69, 95% CI 0.610.79 with SGLT2is) and composite kidney outcomes excluding macroalbuminuria (HR 0.92, 95% CI 0.801.06 with GLP-1RAs and HR 0.55, 95% CI 0.480.64 with SGLT2is) significantly reduced with SGLT2is only
Molecules 25:4410
High-fat foods may sit uncomfortably for extended periods, potentially triggering nausea, discomfort, or vomiting due to this delayed emptying effect